MedPath

Clinical study: Early prediction of tumor response using imaging and molecular biomarkers of hormone sensitive breast cancer in neoadjuvant hormonal therapy setting

Not Applicable
Recruiting
Conditions
Hormonal sensitive breast cancer
Registration Number
JPRN-UMIN000013815
Lead Sponsor
Saitama International Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have already underwent chemotherapy or hormonal therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical response rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath